Q4 2024 Management View CEO Christopher Constant highlighted a successful year marked by $209 million in investments across high-quality convenience and automotive retail assets. The company expanded ...

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...